Day: April 18, 2023

Online Blockchain Quiz helps fans discover which character they channel from the cult classic London, UK, April 18, 2023 (GLOBE NEWSWIRE) — Devotees of The Rocky Horror Show have a new way to connect with their favourite characters and celebrate the production’s 50th anniversary.A new online quiz – designed by The Rocky Horror Show NFTs – is a fun, quick and easy way for fans to learn more about themselves. Participants answer a series of six questions which uncover personality traits, favourite dance moves, fashion choices and more to ultimately reveal which character from The Rocky Horror Show they embody.  Respondents could be the ultimate hedonist like Frank-N-Furter, enigmatic and mysterious like Riff Raff, seemingly innocent like Janet, clean-cut like Brad, quirky and eccentric like Magenta or theatrical and vivacious...

Ongoing physician support ensures highest clinical quality as new therapies gain popularity PURCHASE, N.Y., April 18, 2023 (GLOBE NEWSWIRE) — Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, today announced the expansion of Provider-Based Care for weight management and prediabetes programs. Currently available for diabetes and hypertension programs, the addition of Provider-Based Care services for weight management and diabetes prevention is crucial as 42% of adults in the United States today are estimated to live with obesity and 1 in 3 American adults have prediabetes. Provider-Based Care delivers a unique and integrated care experience for members, including access to a Teladoc Health physician for a personalized care plan, along with coaching for day-to-day guidance with actionable digital tools....

BAYONNE, N.J., April 18, 2023 (GLOBE NEWSWIRE) — BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today reported net income of $8.1 million for the first quarter of 2023, compared to $12.1 million in the fourth quarter of 2022, and $10.0 million for the first quarter of 2022. Earnings per diluted share for the first quarter of 2023 were $0.46, compared to $0.69 in the preceding quarter and $0.56 in the first quarter of 2022. Net income and earnings per diluted share for the first quarter of 2023, adjusted for the unrealized losses on equity investments, were $10.4 million and $0.60, respectively. The Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.16 per share. The dividend will be payable on May 19, 2023 to common shareholders...

JUPITER, Fla., April 18, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial protein production platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 16/640,483, titled “PRODUCTION OF FLU VACCINE IN MYCELIOPHTHORA THERMOPHILA” (the “Patent”), and is expected to provide patent protection through 2038. The Patent will cover claims for the development and manufacture of seasonal and pandemic influenza vaccines...

Intermountain Precision Genomics Laboratory receives certification from NYS Department of Health Clinical Laboratory Evaluation Program SALT LAKE CITY, April 18, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, a service of Intermountain Health, are now certified to offer solid tumor testing to patients in all 50 U.S. states after receiving the New York State Clinical Laboratory Permit. This achievement follows a recent site inspection as part of the New York State Department of Health Clinical Laboratory Evaluation Program. “The NYS certification represents an important step forward in the advancement of precision medicine by increasing access to genetic testing that can help patients with cancer and their providers determine...

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced the Annual General Meeting (AGM) of Shareholders will take place on Wednesday, May 17, 2023 at 16:00 CET (10:00am EDT) at the offices of Allen & Overy LLP, in Amsterdam, the Netherlands. All relevant documents and information for the meeting, including the notice and agenda and explanatory notes, are or will be made available in the “Investors & Media” section of ProQR’s website (www.proqr.com) under “Financials and filings” and then “Shareholder meeting”. The documents will also be made available on the SEC’s website at www.sec.gov. Shareholders...

Uponor Corporation, Investor News, 18 April 2023 at 03:00 pm EEST Invitation: Uponor’s Q1 results briefing on 26 April 2023 Uponor Corporation will publish its interim report for January–March 2023 on Wednesday, 26 April 2023 at around 09:00 am EEST. A live webcast and conference call for analysts, investors and media will be held later on the same day, starting at 02:30 pm EEST at https://uponor.videosync.fi/2023-q1-results, hosted by Uponor Corporation’s President and CEO Michael Rauterkus and CFO Markus Melkko. To ask questions, please participate in the conference call by registering at http://palvelu.flik.fi/teleconference/?id=10010145. After registration you will receive a phone number and conference ID to access the conference call. If you wish to ask a question, please dial *5 on your telephone keypad to enter the queue. All interim...

All 10 patients with late stage melanoma who completed EVX-02 treatment demonstrated robust and treatment-specific immune responses and were relapse-free at their last assessment Results further validate predictive potential of proprietary AI technology and pave the way for advancement of EVX-03, a next-generation DNA-based personalized cancer immunotherapy, into the clinic in Q4COPENHAGEN, Denmark, April 18, 2023 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-powered immunotherapies, today presented promising clinical data from its Phase 1/2a first-in-human study of its DNA-based personalized cancer immunotherapy, EVX-02 in combination with the checkpoint inhibitor nivolumab. Data were presented in the Late Breaking...

The world has lost over 1 trillion trees in the last 100 years. An $11.4 M investment enables Flash Forest mission to plant 1 billion trees by 2028, helping to fight the impacts of climate change MISSISSAUGA, Ontario, April 18, 2023 (GLOBE NEWSWIRE) — Today, Flash Forest, a Canadian reforestation company that uses drones and technology to regenerate post-wildfire areas that are deemed too unsafe for human tree planters, announced the completion of an $11.4 million (CAD) Series A financing round. Climate change is accelerating the frequency and severity of wildfires and we are quickly losing one of our best mechanisms for combating it: trees. Earth loses an average of 26 million hectares of trees every single year. That’s an area roughly the size of Mexico, lost annually. Over 30 per cent of this loss can be attributed to wildfires....